nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium stibogluconate—TOP1—colon cancer	0.556	1	CbGaD
Sodium stibogluconate—TOP1—Irinotecan—colon cancer	0.399	1	CbGbCtD
Sodium stibogluconate—Bronchopneumonia—Capecitabine—colon cancer	0.00121	0.0321	CcSEcCtD
Sodium stibogluconate—Intestinal perforation—Irinotecan—colon cancer	0.000997	0.0265	CcSEcCtD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—BAX—colon cancer	0.000791	0.104	CbGpPWpGaD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—BCL2L1—colon cancer	0.000687	0.0906	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.000605	0.0799	CbGpPWpGaD
Sodium stibogluconate—Intestinal obstruction—Vincristine—colon cancer	0.000594	0.0158	CcSEcCtD
Sodium stibogluconate—Intestinal obstruction—Irinotecan—colon cancer	0.000578	0.0153	CcSEcCtD
Sodium stibogluconate—Lung disorder—Irinotecan—colon cancer	0.000557	0.0148	CcSEcCtD
Sodium stibogluconate—Swelling face—Capecitabine—colon cancer	0.000554	0.0147	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.000509	0.0672	CbGpPWpGaD
Sodium stibogluconate—Intestinal perforation—Methotrexate—colon cancer	0.000497	0.0132	CcSEcCtD
Sodium stibogluconate—Venous thrombosis—Capecitabine—colon cancer	0.000489	0.013	CcSEcCtD
Sodium stibogluconate—Necrosis—Fluorouracil—colon cancer	0.000481	0.0128	CcSEcCtD
Sodium stibogluconate—Tingling sensation—Fluorouracil—colon cancer	0.00047	0.0125	CcSEcCtD
Sodium stibogluconate—Extravasation—Vincristine—colon cancer	0.000464	0.0123	CcSEcCtD
Sodium stibogluconate—Extravasation—Irinotecan—colon cancer	0.000452	0.012	CcSEcCtD
Sodium stibogluconate—Tenderness—Fluorouracil—colon cancer	0.000433	0.0115	CcSEcCtD
Sodium stibogluconate—Extravasation—Fluorouracil—colon cancer	0.000433	0.0115	CcSEcCtD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—CASP3—colon cancer	0.000425	0.0561	CbGpPWpGaD
Sodium stibogluconate—Ulcer—Irinotecan—colon cancer	0.000417	0.0111	CcSEcCtD
Sodium stibogluconate—Cellulitis—Fluorouracil—colon cancer	0.000415	0.011	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.000407	0.0537	CbGpPWpGaD
Sodium stibogluconate—Ulcer—Fluorouracil—colon cancer	0.000399	0.0106	CcSEcCtD
Sodium stibogluconate—Intestinal obstruction—Capecitabine—colon cancer	0.000387	0.0103	CcSEcCtD
Sodium stibogluconate—Sepsis—Irinotecan—colon cancer	0.000342	0.00908	CcSEcCtD
Sodium stibogluconate—Coagulopathy—Capecitabine—colon cancer	0.000339	0.00899	CcSEcCtD
Sodium stibogluconate—Tingling sensation—Capecitabine—colon cancer	0.000328	0.00871	CcSEcCtD
Sodium stibogluconate—Sepsis—Fluorouracil—colon cancer	0.000328	0.00869	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.000318	0.042	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.000312	0.0412	CbGpPWpGaD
Sodium stibogluconate—Swelling—Fluorouracil—colon cancer	0.000311	0.00824	CcSEcCtD
Sodium stibogluconate—Renal failure acute—Irinotecan—colon cancer	0.00031	0.00822	CcSEcCtD
Sodium stibogluconate—Disorientation—Fluorouracil—colon cancer	0.000306	0.00813	CcSEcCtD
Sodium stibogluconate—Renal impairment—Irinotecan—colon cancer	0.000301	0.00798	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.000301	0.0397	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—TYMS—colon cancer	0.0003	0.0396	CbGpPWpGaD
Sodium stibogluconate—Hyponatraemia—Vincristine—colon cancer	0.000295	0.00783	CcSEcCtD
Sodium stibogluconate—Cerebrovascular accident—Irinotecan—colon cancer	0.000292	0.00775	CcSEcCtD
Sodium stibogluconate—Cellulitis—Capecitabine—colon cancer	0.00029	0.0077	CcSEcCtD
Sodium stibogluconate—Hypocalcaemia—Capecitabine—colon cancer	0.000288	0.00765	CcSEcCtD
Sodium stibogluconate—Hyponatraemia—Irinotecan—colon cancer	0.000287	0.00762	CcSEcCtD
Sodium stibogluconate—Ulcer—Capecitabine—colon cancer	0.000279	0.0074	CcSEcCtD
Sodium stibogluconate—Cyanosis—Methotrexate—colon cancer	0.000277	0.00736	CcSEcCtD
Sodium stibogluconate—Lung disorder—Methotrexate—colon cancer	0.000277	0.00736	CcSEcCtD
Sodium stibogluconate—Dehydration—Vincristine—colon cancer	0.000273	0.00725	CcSEcCtD
Sodium stibogluconate—Blood creatinine increased—Irinotecan—colon cancer	0.000268	0.00711	CcSEcCtD
Sodium stibogluconate—Dehydration—Irinotecan—colon cancer	0.000266	0.00706	CcSEcCtD
Sodium stibogluconate—Irritability—Fluorouracil—colon cancer	0.000262	0.00694	CcSEcCtD
Sodium stibogluconate—Hypokalaemia—Irinotecan—colon cancer	0.00026	0.00691	CcSEcCtD
Sodium stibogluconate—Fluid retention—Capecitabine—colon cancer	0.00025	0.00665	CcSEcCtD
Sodium stibogluconate—Necrosis—Methotrexate—colon cancer	0.00025	0.00664	CcSEcCtD
Sodium stibogluconate—Abdominal distension—Irinotecan—colon cancer	0.000249	0.00661	CcSEcCtD
Sodium stibogluconate—Abscess—Methotrexate—colon cancer	0.000248	0.00659	CcSEcCtD
Sodium stibogluconate—Sweating increased—Irinotecan—colon cancer	0.000241	0.00639	CcSEcCtD
Sodium stibogluconate—Dysphagia—Fluorouracil—colon cancer	0.000237	0.00628	CcSEcCtD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—AKT1—colon cancer	0.00023	0.0304	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000229	0.0302	CbGpPWpGaD
Sodium stibogluconate—Sepsis—Capecitabine—colon cancer	0.000229	0.00607	CcSEcCtD
Sodium stibogluconate—Extravasation—Methotrexate—colon cancer	0.000225	0.00597	CcSEcCtD
Sodium stibogluconate—Acute coronary syndrome—Vincristine—colon cancer	0.000223	0.00592	CcSEcCtD
Sodium stibogluconate—Phlebitis—Capecitabine—colon cancer	0.000222	0.0059	CcSEcCtD
Sodium stibogluconate—Myocardial infarction—Vincristine—colon cancer	0.000222	0.00589	CcSEcCtD
Sodium stibogluconate—Acute coronary syndrome—Irinotecan—colon cancer	0.000217	0.00577	CcSEcCtD
Sodium stibogluconate—Swelling—Capecitabine—colon cancer	0.000217	0.00576	CcSEcCtD
Sodium stibogluconate—Renal failure—Irinotecan—colon cancer	0.000217	0.00575	CcSEcCtD
Sodium stibogluconate—Myocardial infarction—Irinotecan—colon cancer	0.000216	0.00574	CcSEcCtD
Sodium stibogluconate—Oliguria—Methotrexate—colon cancer	0.000213	0.00565	CcSEcCtD
Sodium stibogluconate—TOP1—Circadian rythm related genes—PPARG—colon cancer	0.000212	0.028	CbGpPWpGaD
Sodium stibogluconate—Acute coronary syndrome—Fluorouracil—colon cancer	0.000208	0.00552	CcSEcCtD
Sodium stibogluconate—Ulcer—Methotrexate—colon cancer	0.000208	0.00551	CcSEcCtD
Sodium stibogluconate—Renal failure acute—Capecitabine—colon cancer	0.000207	0.0055	CcSEcCtD
Sodium stibogluconate—Myocardial infarction—Fluorouracil—colon cancer	0.000207	0.00549	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Vincristine—colon cancer	0.000202	0.00537	CcSEcCtD
Sodium stibogluconate—Renal impairment—Capecitabine—colon cancer	0.000201	0.00534	CcSEcCtD
Sodium stibogluconate—Cerebrovascular accident—Capecitabine—colon cancer	0.000195	0.00519	CcSEcCtD
Sodium stibogluconate—Hyponatraemia—Capecitabine—colon cancer	0.000192	0.0051	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Fluorouracil—colon cancer	0.000189	0.00501	CcSEcCtD
Sodium stibogluconate—Irritability—Capecitabine—colon cancer	0.000183	0.00485	CcSEcCtD
Sodium stibogluconate—Blood creatinine increased—Capecitabine—colon cancer	0.000179	0.00476	CcSEcCtD
Sodium stibogluconate—Dehydration—Capecitabine—colon cancer	0.000178	0.00473	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Irinotecan—colon cancer	0.000177	0.00469	CcSEcCtD
Sodium stibogluconate—Hypokalaemia—Capecitabine—colon cancer	0.000174	0.00462	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.000174	0.023	CbGpPWpGaD
Sodium stibogluconate—Sepsis—Methotrexate—colon cancer	0.00017	0.00452	CcSEcCtD
Sodium stibogluconate—Flatulence—Irinotecan—colon cancer	0.00017	0.00451	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Fluorouracil—colon cancer	0.000169	0.00449	CcSEcCtD
Sodium stibogluconate—Abdominal distension—Capecitabine—colon cancer	0.000167	0.00442	CcSEcCtD
Sodium stibogluconate—Dysphagia—Capecitabine—colon cancer	0.000166	0.00439	CcSEcCtD
Sodium stibogluconate—Bronchospasm—Capecitabine—colon cancer	0.000163	0.00432	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000161	0.0213	CbGpPWpGaD
Sodium stibogluconate—Sweating increased—Capecitabine—colon cancer	0.000161	0.00428	CcSEcCtD
Sodium stibogluconate—Bronchitis—Capecitabine—colon cancer	0.000159	0.00422	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.000157	0.0207	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.000156	0.0205	CbGpPWpGaD
Sodium stibogluconate—Vision blurred—Fluorouracil—colon cancer	0.000156	0.00413	CcSEcCtD
Sodium stibogluconate—Syncope—Irinotecan—colon cancer	0.000155	0.0041	CcSEcCtD
Sodium stibogluconate—Renal failure acute—Methotrexate—colon cancer	0.000154	0.0041	CcSEcCtD
Sodium stibogluconate—Convulsion—Vincristine—colon cancer	0.000153	0.00407	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.000152	0.0201	CbGpPWpGaD
Sodium stibogluconate—Loss of consciousness—Irinotecan—colon cancer	0.000151	0.00402	CcSEcCtD
Sodium stibogluconate—Acute coronary syndrome—Capecitabine—colon cancer	0.000145	0.00386	CcSEcCtD
Sodium stibogluconate—Cerebrovascular accident—Methotrexate—colon cancer	0.000145	0.00386	CcSEcCtD
Sodium stibogluconate—Renal failure—Capecitabine—colon cancer	0.000145	0.00385	CcSEcCtD
Sodium stibogluconate—Myocardial infarction—Capecitabine—colon cancer	0.000145	0.00384	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.000145	0.0191	CbGpPWpGaD
Sodium stibogluconate—Anaphylactic shock—Vincristine—colon cancer	0.000144	0.00383	CcSEcCtD
Sodium stibogluconate—Oedema—Vincristine—colon cancer	0.000144	0.00383	CcSEcCtD
Sodium stibogluconate—Infection—Vincristine—colon cancer	0.000143	0.00381	CcSEcCtD
Sodium stibogluconate—Convulsion—Fluorouracil—colon cancer	0.000143	0.00379	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.000141	0.0186	CbGpPWpGaD
Sodium stibogluconate—Oedema—Irinotecan—colon cancer	0.000141	0.00373	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Irinotecan—colon cancer	0.000141	0.00373	CcSEcCtD
Sodium stibogluconate—Chest pain—Fluorouracil—colon cancer	0.000141	0.00373	CcSEcCtD
Sodium stibogluconate—Infection—Irinotecan—colon cancer	0.00014	0.00371	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Vincristine—colon cancer	0.00014	0.0037	CcSEcCtD
Sodium stibogluconate—TOP1—Circadian rythm related genes—EP300—colon cancer	0.000139	0.0183	CbGpPWpGaD
Sodium stibogluconate—Shock—Irinotecan—colon cancer	0.000138	0.00367	CcSEcCtD
Sodium stibogluconate—Anorexia—Vincristine—colon cancer	0.000138	0.00365	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000137	0.0181	CbGpPWpGaD
Sodium stibogluconate—Irritability—Methotrexate—colon cancer	0.000136	0.00361	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Irinotecan—colon cancer	0.000136	0.00361	CcSEcCtD
Sodium stibogluconate—Hypotension—Vincristine—colon cancer	0.000135	0.00358	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Fluorouracil—colon cancer	0.000135	0.00357	CcSEcCtD
Sodium stibogluconate—Oedema—Fluorouracil—colon cancer	0.000135	0.00357	CcSEcCtD
Sodium stibogluconate—Anorexia—Irinotecan—colon cancer	0.000134	0.00356	CcSEcCtD
Sodium stibogluconate—Infection—Fluorouracil—colon cancer	0.000134	0.00355	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Capecitabine—colon cancer	0.000132	0.0035	CcSEcCtD
Sodium stibogluconate—Tachycardia—Fluorouracil—colon cancer	0.000131	0.00349	CcSEcCtD
Sodium stibogluconate—Hypotension—Irinotecan—colon cancer	0.000131	0.00349	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Vincristine—colon cancer	0.00013	0.00344	CcSEcCtD
Sodium stibogluconate—Anorexia—Fluorouracil—colon cancer	0.000128	0.00341	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Irinotecan—colon cancer	0.000126	0.00335	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.000126	0.0166	CbGpPWpGaD
Sodium stibogluconate—Hypotension—Fluorouracil—colon cancer	0.000126	0.00334	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.000126	0.0166	CbGpPWpGaD
Sodium stibogluconate—Decreased appetite—Vincristine—colon cancer	0.000126	0.00333	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Irinotecan—colon cancer	0.000125	0.00333	CcSEcCtD
Sodium stibogluconate—Fatigue—Vincristine—colon cancer	0.000124	0.0033	CcSEcCtD
Sodium stibogluconate—Constipation—Vincristine—colon cancer	0.000123	0.00328	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.000123	0.0163	CbGpPWpGaD
Sodium stibogluconate—Decreased appetite—Irinotecan—colon cancer	0.000122	0.00324	CcSEcCtD
Sodium stibogluconate—Fatigue—Irinotecan—colon cancer	0.000121	0.00322	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Fluorouracil—colon cancer	0.000121	0.00321	CcSEcCtD
Sodium stibogluconate—Constipation—Irinotecan—colon cancer	0.00012	0.00319	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Fluorouracil—colon cancer	0.00012	0.00319	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Capecitabine—colon cancer	0.000118	0.00314	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Vincristine—colon cancer	0.000118	0.00313	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Fluorouracil—colon cancer	0.000117	0.00311	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.000116	0.0154	CbGpPWpGaD
Sodium stibogluconate—Gastrointestinal pain—Irinotecan—colon cancer	0.000115	0.00305	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Vincristine—colon cancer	0.000114	0.00303	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Vincristine—colon cancer	0.000114	0.00303	CcSEcCtD
Sodium stibogluconate—Flatulence—Capecitabine—colon cancer	0.000114	0.00302	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Capecitabine—colon cancer	0.000113	0.003	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Irinotecan—colon cancer	0.000111	0.00295	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Irinotecan—colon cancer	0.000111	0.00295	CcSEcCtD
Sodium stibogluconate—Vision blurred—Capecitabine—colon cancer	0.000109	0.00288	CcSEcCtD
Sodium stibogluconate—Renal failure—Methotrexate—colon cancer	0.000108	0.00287	CcSEcCtD
Sodium stibogluconate—Urticaria—Fluorouracil—colon cancer	0.000107	0.00284	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000107	0.0141	CbGpPWpGaD
Sodium stibogluconate—Body temperature increased—Fluorouracil—colon cancer	0.000106	0.00283	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Vincristine—colon cancer	0.000106	0.00282	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Irinotecan—colon cancer	0.000104	0.00275	CcSEcCtD
Sodium stibogluconate—Asthenia—Vincristine—colon cancer	0.000104	0.00275	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.000104	0.0137	CbGpPWpGaD
Sodium stibogluconate—Syncope—Capecitabine—colon cancer	0.000103	0.00274	CcSEcCtD
Sodium stibogluconate—Palpitations—Capecitabine—colon cancer	0.000102	0.0027	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Capecitabine—colon cancer	0.000101	0.00269	CcSEcCtD
Sodium stibogluconate—Asthenia—Irinotecan—colon cancer	0.000101	0.00268	CcSEcCtD
Sodium stibogluconate—TOP1—Circadian rythm related genes—TP53—colon cancer	9.94e-05	0.0131	CbGpPWpGaD
Sodium stibogluconate—Hypersensitivity—Fluorouracil—colon cancer	9.92e-05	0.00263	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Vincristine—colon cancer	9.88e-05	0.00262	CcSEcCtD
Sodium stibogluconate—Chest pain—Capecitabine—colon cancer	9.82e-05	0.00261	CcSEcCtD
Sodium stibogluconate—Anxiety—Capecitabine—colon cancer	9.78e-05	0.0026	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Irinotecan—colon cancer	9.62e-05	0.00255	CcSEcCtD
Sodium stibogluconate—Dizziness—Vincristine—colon cancer	9.55e-05	0.00253	CcSEcCtD
Sodium stibogluconate—Pruritus—Fluorouracil—colon cancer	9.53e-05	0.00253	CcSEcCtD
Sodium stibogluconate—Oedema—Capecitabine—colon cancer	9.41e-05	0.0025	CcSEcCtD
Sodium stibogluconate—Infection—Capecitabine—colon cancer	9.35e-05	0.00248	CcSEcCtD
Sodium stibogluconate—Dizziness—Irinotecan—colon cancer	9.3e-05	0.00247	CcSEcCtD
Sodium stibogluconate—Shock—Capecitabine—colon cancer	9.26e-05	0.00246	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Fluorouracil—colon cancer	9.22e-05	0.00245	CcSEcCtD
Sodium stibogluconate—Tachycardia—Capecitabine—colon cancer	9.19e-05	0.00244	CcSEcCtD
Sodium stibogluconate—Vomiting—Vincristine—colon cancer	9.18e-05	0.00244	CcSEcCtD
Sodium stibogluconate—Rash—Vincristine—colon cancer	9.1e-05	0.00242	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Capecitabine—colon cancer	9.1e-05	0.00241	CcSEcCtD
Sodium stibogluconate—Dermatitis—Vincristine—colon cancer	9.1e-05	0.00241	CcSEcCtD
Sodium stibogluconate—Headache—Vincristine—colon cancer	9.05e-05	0.0024	CcSEcCtD
Sodium stibogluconate—Anorexia—Capecitabine—colon cancer	8.97e-05	0.00238	CcSEcCtD
Sodium stibogluconate—Vomiting—Irinotecan—colon cancer	8.94e-05	0.00237	CcSEcCtD
Sodium stibogluconate—Dizziness—Fluorouracil—colon cancer	8.91e-05	0.00236	CcSEcCtD
Sodium stibogluconate—Rash—Irinotecan—colon cancer	8.87e-05	0.00235	CcSEcCtD
Sodium stibogluconate—Dermatitis—Irinotecan—colon cancer	8.86e-05	0.00235	CcSEcCtD
Sodium stibogluconate—Headache—Irinotecan—colon cancer	8.81e-05	0.00234	CcSEcCtD
Sodium stibogluconate—Hypotension—Capecitabine—colon cancer	8.79e-05	0.00233	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	8.74e-05	0.0115	CbGpPWpGaD
Sodium stibogluconate—Nausea—Vincristine—colon cancer	8.58e-05	0.00228	CcSEcCtD
Sodium stibogluconate—Vomiting—Fluorouracil—colon cancer	8.56e-05	0.00227	CcSEcCtD
Sodium stibogluconate—Rash—Fluorouracil—colon cancer	8.49e-05	0.00225	CcSEcCtD
Sodium stibogluconate—Dermatitis—Fluorouracil—colon cancer	8.48e-05	0.00225	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Capecitabine—colon cancer	8.45e-05	0.00224	CcSEcCtD
Sodium stibogluconate—Headache—Fluorouracil—colon cancer	8.44e-05	0.00224	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Methotrexate—colon cancer	8.41e-05	0.00223	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Capecitabine—colon cancer	8.39e-05	0.00223	CcSEcCtD
Sodium stibogluconate—Nausea—Irinotecan—colon cancer	8.35e-05	0.00222	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Capecitabine—colon cancer	8.18e-05	0.00217	CcSEcCtD
Sodium stibogluconate—Fatigue—Capecitabine—colon cancer	8.11e-05	0.00215	CcSEcCtD
Sodium stibogluconate—Vision blurred—Methotrexate—colon cancer	8.09e-05	0.00215	CcSEcCtD
Sodium stibogluconate—Constipation—Capecitabine—colon cancer	8.05e-05	0.00214	CcSEcCtD
Sodium stibogluconate—Nausea—Fluorouracil—colon cancer	8e-05	0.00212	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Capecitabine—colon cancer	7.7e-05	0.00204	CcSEcCtD
Sodium stibogluconate—Urticaria—Capecitabine—colon cancer	7.48e-05	0.00198	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Capecitabine—colon cancer	7.44e-05	0.00197	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Capecitabine—colon cancer	7.44e-05	0.00197	CcSEcCtD
Sodium stibogluconate—Convulsion—Methotrexate—colon cancer	7.44e-05	0.00197	CcSEcCtD
Sodium stibogluconate—Chest pain—Methotrexate—colon cancer	7.31e-05	0.00194	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Methotrexate—colon cancer	7.01e-05	0.00186	CcSEcCtD
Sodium stibogluconate—Infection—Methotrexate—colon cancer	6.96e-05	0.00185	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Capecitabine—colon cancer	6.93e-05	0.00184	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Methotrexate—colon cancer	6.77e-05	0.0018	CcSEcCtD
Sodium stibogluconate—Asthenia—Capecitabine—colon cancer	6.75e-05	0.00179	CcSEcCtD
Sodium stibogluconate—Anorexia—Methotrexate—colon cancer	6.68e-05	0.00177	CcSEcCtD
Sodium stibogluconate—Pruritus—Capecitabine—colon cancer	6.66e-05	0.00177	CcSEcCtD
Sodium stibogluconate—Hypotension—Methotrexate—colon cancer	6.55e-05	0.00174	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Capecitabine—colon cancer	6.44e-05	0.00171	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Methotrexate—colon cancer	6.29e-05	0.00167	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Methotrexate—colon cancer	6.25e-05	0.00166	CcSEcCtD
Sodium stibogluconate—Dizziness—Capecitabine—colon cancer	6.22e-05	0.00165	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Methotrexate—colon cancer	6.09e-05	0.00162	CcSEcCtD
Sodium stibogluconate—Fatigue—Methotrexate—colon cancer	6.04e-05	0.0016	CcSEcCtD
Sodium stibogluconate—Vomiting—Capecitabine—colon cancer	5.98e-05	0.00159	CcSEcCtD
Sodium stibogluconate—Rash—Capecitabine—colon cancer	5.93e-05	0.00157	CcSEcCtD
Sodium stibogluconate—Dermatitis—Capecitabine—colon cancer	5.93e-05	0.00157	CcSEcCtD
Sodium stibogluconate—Headache—Capecitabine—colon cancer	5.9e-05	0.00156	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Methotrexate—colon cancer	5.73e-05	0.00152	CcSEcCtD
Sodium stibogluconate—Nausea—Capecitabine—colon cancer	5.59e-05	0.00148	CcSEcCtD
Sodium stibogluconate—Urticaria—Methotrexate—colon cancer	5.57e-05	0.00148	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Methotrexate—colon cancer	5.54e-05	0.00147	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Methotrexate—colon cancer	5.54e-05	0.00147	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Methotrexate—colon cancer	5.16e-05	0.00137	CcSEcCtD
Sodium stibogluconate—Asthenia—Methotrexate—colon cancer	5.03e-05	0.00133	CcSEcCtD
Sodium stibogluconate—Pruritus—Methotrexate—colon cancer	4.96e-05	0.00132	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Methotrexate—colon cancer	4.79e-05	0.00127	CcSEcCtD
Sodium stibogluconate—Dizziness—Methotrexate—colon cancer	4.63e-05	0.00123	CcSEcCtD
Sodium stibogluconate—Vomiting—Methotrexate—colon cancer	4.45e-05	0.00118	CcSEcCtD
Sodium stibogluconate—Rash—Methotrexate—colon cancer	4.42e-05	0.00117	CcSEcCtD
Sodium stibogluconate—Dermatitis—Methotrexate—colon cancer	4.41e-05	0.00117	CcSEcCtD
Sodium stibogluconate—Headache—Methotrexate—colon cancer	4.39e-05	0.00116	CcSEcCtD
Sodium stibogluconate—Nausea—Methotrexate—colon cancer	4.16e-05	0.0011	CcSEcCtD
